EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive Potential of RNA Polymerase B (II) Subunit 1 (RPB1) Cytoplasmic Aggregation for Neoadjuvant Chemotherapy Failure

Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög iD, Barbara N Borsos, Hajnalka Majoros iD, Zsuzsanna Ujfaludi iD, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi und 10 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bence Nagy-Mikó und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Szeged, 52 Középfasor, H-6726 Szeged, Hungary. Hauptthemen laut MEDLINE: RNA Polymerase II, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian National Research, Development and Innovation Office, János Bolyai Research Scholarship of the Hungarian Academy of Sciences, EU’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buffer transcription under genotoxic stress. As an indicator for such an event, we followed the cytoplasmic aggregation of RPB1, the aggregation-prone largest subunit of RNA polymerase II, in biopsy samples taken from patients with invasive carcinoma of no special type. RPB1 frequently aggregates co-translationally in the absence of proper HSP90 chaperone function or in ribosome mutant cells as revealed formerly in yeast. We found that cytoplasmic foci of RPB1 occur in larger sizes in tumors that showed no regression after therapy. Based on these results, we propose that monitoring the cytoplasmic aggregation of RPB1 may be suitable for determining—from biopsy samples taken before treatment—the effectiveness of neoadjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IISaccharomyces cerevisiae ProteinsHumansNeoadjuvant TherapyProtein AggregatesSaccharomyces cerevisiae

Stichwörter der Autor:innen

CCR4-NOTRNAPIIRPB1aggregationassemblysomescondensatesepirubicininvasive carcinoma of no special typeneoadjuvant therapy

Substanzen

RNA Polymerase IIProtein AggregatesSaccharomyces cerevisiae ProteinsRPB1 protein, S cerevisiae

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Szeged, 52 Középfasor, H-6726 Szeged, Hungary.
  • Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Állomás utca 1, H-6725 Szeged, Hungary.
  • Competence Centre of the Life Sciences Cluster of the Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Dugonics tér 13, H-6720 Szeged, Hungary.
  • Department of Oncotherapy, Albert Szent-Györgyi Health Centre, University of Szeged, 12 Korányi Fasor, H-6720 Szeged, Hungary.
  • Department of Surgery, Albert Szent-Györgyi Health Centre, University of Szeged, 8 Semmelweis Street, H-6725 Szeged, Hungary.
  • Department of Radiology, Albert Szent-Györgyi Health Centre, University of Szeged, 6 Semmelweis Street, H-6725 Szeged, Hungary.

ORCID-Profile: Nóra Ördög, Hajnalka Majoros, Zsuzsanna Ujfaludi, Tibor Pankotai, Zoltán Villányi, András Vörös

Förderung

  • Hungarian National Research, Development and Innovation Office
  • János Bolyai Research Scholarship of the Hungarian Academy of Sciences
  • EU’s Horizon 2020 research and innovation program
  • Hungary from the National Research, Development and Innovation Fund

Zitieren

APA

Nagy-Mikó, B., Németh-Szatmári, O., Faragó-Mészáros, R., Csókási, A., Bognár, B., Ördög, N., Borsos, B. N., Majoros, H., Ujfaludi, Z., Oláh-Németh, O., Nikolényi, A., Dobi, Á., Kószó, R., Sántha, D., Lázár, G., Simonka, Z., Paszt, A., Ormándi, K., Pankotai, T., …, & Vörös, A. (2023). Predictive Potential of RNA Polymerase B (II) Subunit 1 (RPB1) Cytoplasmic Aggregation for Neoadjuvant Chemotherapy Failure. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115869

Vancouver

Nagy-Mikó B, Németh-Szatmári O, Faragó-Mészáros R, Csókási A, Bognár B, Ördög N, et al. Predictive Potential of RNA Polymerase B (II) Subunit 1 (RPB1) Cytoplasmic Aggregation for Neoadjuvant Chemotherapy Failure. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115869

BibTeX
@article{NagyMik2023,
  author = {Nagy-Mikó, Bence and Németh-Szatmári, Orsolya and Faragó-Mészáros, Réka and Csókási, Aliz and Bognár, Bence and Ördög, Nóra and Borsos, Barbara N and Majoros, Hajnalka and Ujfaludi, Zsuzsanna and Oláh-Németh, Orsolya and Nikolényi, Aliz and Dobi, Ágnes and Kószó, Renáta and Sántha, Dóra and Lázár, György and Simonka, Zsolt and Paszt, Attila and Ormándi, Katalin and Pankotai, Tibor and Boros, Imre M and Villányi, Zoltán and Vörös, András},
  title = {Predictive Potential of RNA Polymerase B (II) Subunit 1 (RPB1) Cytoplasmic Aggregation for Neoadjuvant Chemotherapy Failure},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115869}
}
Kostenlos starten →